Termination Reimbursement scheme Adhesa®

Due to changes in market conditions, the reimbursement scheme for Adhesa will end on 1 May 2026.

Conditions

This means that dispensations up to and including 1 May 2026 can still be submitted until 31 July 2026. After that date (from 1 August 2026 onward), no further claims will be processed.

Who can submit claims

Only patients or their caregivers may claim the out-of-pocket contribution for Adhesa^® 5 mg tablets, either online or by post. Pharmacists are not permitted to submit claims on behalf of patients.

For more information, please refer to the medication page for Adhesa® 5 mg tablets.